Skip to content

Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy

Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01588730
Enrollment
26
Registered
2012-05-01
Start date
2011-06-30
Completion date
Unknown
Last updated
2013-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis, Plantar Fasciopathy

Keywords

PF, Dynasplint, ADFD, AFD, Plantar Fasciitis, plantar Fasciopathy

Brief summary

The purpose of this study is to compare the Ankle Dorsiflexion Dynasplint System (DS) to static night splint for the reduction of pain from Plantar Fasciitis (Fasciopathy).

Interventions

Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours) and, this does not affect activities of daily living

PROCEDURECommercially Available Static Night splint

A commericially avilable static night splint will be worn for 4-6 hours during rest.

Sponsors

Dynasplint Systems, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients will have had a history of at least 3 consecutive months of plantar heel pain well-localized to the plantar fascia. * All patients will have failed an initial treatment of non-weight bearing plantar and Achilles stretching. * Diagnosis will be confirmed by physical examination by a single physician (JPF) with a typical point of maximum tenderness over the medial tubercle of the calcaneus

Exclusion criteria

* rheumatoid arthritis * local infection * pregnancy * patients with tumors * unresolved fractures * severe peripheral vascular disease * history of prior plantar fascia surgery * history of plantar fascia rupture * age \<18 years * recent ( within 6 weeks) steroid injection

Design outcomes

Primary

MeasureTime frameDescription
FFI score16 weeksThe primary outcome measure will be difference between the pretreatment and two month cumulative Foot Function Index (PS-FFI) score

Secondary

MeasureTime frameDescription
Pain subscale and SROM questionnaire2, 4 and 12 monthsSecondary outcome measures will include two month, four month, and twelve month overall heel pain reduction measured by the responses to the following questionnaires: 1. Pain subscale of the validated Foot Function Index (PS-FFI) 2. A patient-relevant outcome measures (SROM) questionnaire that included generic and condition -specific outcome measures related to pain, function, and satisfaction with the treatment outcome.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026